You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

disease-modifying antirheumatic drugs (DMARDs)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tofacitinib Special Investigation for Rheumatoid Arthritis

Completed
  • Rheumatoid Arthritis
  • Tofacitinib (Xeljanz)
  • Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc
  • Tokyo, Japan
    (unnamed)
Sep 27, 2021

Rheumatoid Arthritis (RA) Trial in China, Korea, Republic of, Taiwan (Peficitinib, Plaebo, Disease-modifying antirheumatic drugs

Completed
  • Rheumatoid Arthritis (RA)
  • Anhui, China
  • +42 more
Jan 7, 2023

Rheumatoid Arthritis Patients Treated With Tofacitinib Or

Completed
Has Results
  • Arthritis, Rheumatoid
    • Medellin, Antioquia, Colombia
    • +12 more
    Oct 20, 2020

    Predictive Factors for COVID-19 in Rheumatology

    Not yet recruiting
    • Rheumatic Diseases
    • Covid19
    • Disease-modifying antirheumatic drugs (DMARDs)
    • (no location specified)
    Sep 24, 2020

    Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs

    Completed
    • Arthritis, Rheumatoid
      • Tokyo, Japan
        Pfizer
      Nov 28, 2022

      National Data Bank for Rheumatic Disease Registry Study of

      Completed
      • Rheumatoid Arthritis
        • (no location specified)
        Jul 15, 2020

        Rheumatoid Arthritis Trial in Dhaka (Vitamin D3)

        Completed
        • Rheumatoid Arthritis
        • Vitamin D3
        • Dhaka, Bangladesh
          BSMMU
        Feb 1, 2022

        Rheumatoid Arthritis Trial in Tokyo (denosumab, )

        Completed
        Has Results
        • Rheumatoid Arthritis
        • Tokyo, Japan
          (unnamed)
        Feb 3, 2020

        Rheumatoid Arthritis Trial in New York (TNF inhibitors, DMARDs)

        Completed
        Has Results
        • Rheumatoid Arthritis
        • New York, New York
          Columbia University Medical Center
        Nov 4, 2020

        Rheumatoid Arthritis Trial in Norway (TNF inhibitors, Synthetic DMARD(s), Co-medication: Synthetic DMARDs)

        Active, not recruiting
        • Rheumatoid Arthritis
        • TNF inhibitors
        • +2 more
        • Bergen, Norway
        • +9 more
        Sep 14, 2020

        Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

        Completed
        • Rheumatoid Arthritis
        • Pondicherry, Pondicherry UT, India
          Jawaharlal Institute of Postgraduate Medical Education & Researc
        Sep 28, 2019

        Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

        Completed
        • Multiple Sclerosis
        • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
        • Prague, Czechia
          IMPULS Endowment Fund
        Mar 7, 2023

        The Norwegian Antirheumatic Drug Register

        Recruiting
        • Inflammatory Joint Diseases
          • Drammen, Buskerud, Norway
          • +5 more
          Aug 19, 2022

          Rheumatoid Arthritis Trial (GS-5718, Placebo to match GS-5718, Tofacitinib 5 mg)

          Withdrawn
          • Rheumatoid Arthritis
          • (no location specified)
          May 11, 2022

          Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

          Terminated
          Has Results
          • Rheumatoid Arthritis
          • Pondicherry, India
            Department of Clinical Immunology , Jawaharlal Institute of Post
          Jul 25, 2021

          Rheumatoid Arthritis Trial in Pierre-Bénite, Lyon (Pharmaceutical care in multiprofessional collaboration)

          Recruiting
          • Rheumatoid Arthritis
          • Pharmaceutical care in multiprofessional collaboration
          • Pierre-Bénite, Lyon, France
          • +1 more
          Jun 30, 2022

          Rheumatoid Arthritis, DMARD-naive and Early Disease Patients Trial in Prague (CR6086, Methotrexate, Placebo)

          Completed
          • Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
          • Prague, Czechia
            Institute of Rheumatology
          Oct 4, 2021

          d in the Treatment of Multiple Sclerosis

          Not yet recruiting
          • Multiple Sclerosis
          • Measurement of concentrations of orally-used DMDs
          • +3 more
          • Ostrava, Moravian-Silesian Region, Czechia
          • +1 more
          Dec 5, 2022

          Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")

          Not yet recruiting
          • Rheumatoid Arthritis
          • "apigenin" and "glycyrrhizin"
          • +2 more
          • (no location specified)
          Mar 27, 2023

          Rheumatoid Arthritis Trial in Cairo (Cilostazol 100 MG, conventional synthetic antirheumatic drugs)

          Recruiting
          • Rheumatoid Arthritis
          • Cilostazol 100 MG
          • conventional synthetic antirheumatic drugs
          • Cairo, Egypt
            Al-Zahraa Hospital
          Dec 26, 2022

          Moderated to Severe Rheumatoid Arthritis Who Have Failed to

          Completed
          • Arthritis, Rheumatoid
            • Ilsan, Gyeonggi-do, Korea, Republic of
            • +14 more
            Dec 14, 2020

            Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

            Not yet recruiting
            • Rheumatoid Arthritis
            • Observation
            • (no location specified)
            Oct 8, 2022

            SAPHO Syndrome Trial in Warsaw (Etanercept, Placebo)

            Recruiting
            • SAPHO Syndrome
            • Warsaw, Mazowieckie, Poland
              Centrum Wsparcia Badań Klinicznych
            Aug 29, 2023

            CNS Inflammatory Demyelinating Diseases

            Not yet recruiting
            • Multiple Sclerosis
            • +4 more
            • Intravenous steroid
            • (no location specified)
            Nov 29, 2021

            Learn About Interferon-beta Exposure of Pregnant Women During

            Not yet recruiting
            • Multiple Sclerosis (MS)
            • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
            • +5 more
            • Multiple Locations, Finland
            • +1 more
            Sep 19, 2023